The monoclonal antibody cetuximab (Erbitux) was approved by the FDA for the treatment of metastatic colorectal cancer
On Feb. 1, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved Cetuximab, a recombinant…
On Feb. 1, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved Cetuximab, a recombinant…
In 2003, two randomized controlled trials showed that taking aspirin daily for as little as three years reduces…
On Nov. 19, 1999, National Colorectal Cancer Awareness Month was established with a declaration by the U.S. Senate,…